Federal Register / Vol. 65, No. 215 / Monday, November 6, 2000 / Notices 66547

ANNUAL BURDEN ESTIMATES

Instrument Number of

respondents

Number of responses per

respondents

Average burden hours per

response

Total burden

hours

Case Plan ........................................................................................................ 714,056 1 2.62 1,870,827

Estimated Total Annual Burden Hours: .................................................... ........................ ........................ ........................ 1,870,827

In compliance with the requirements

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Administration for Children and

Families is soliciting public comment

on the specific aspects of the

information collection described above.

Copies of the proposed collection of

information can be obtained and

comments may be forwarded by writing

to the Administration for Children and

Families, Office of Information Services,

370 L’Enfant Promenade, SW.,

Washington, DC 20447, Attn: ACF

Reports Clearance Officer. All requests

should be identified by the title of the

information collection.

The Department specifically requests

comments on: (a) Whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

the quality, utility, and clarity of the

information to be collected; and (d)

ways to minimize the burden of the

collection of information on

respondents, including through the use

of automated collection techniques or

other forms of information technology.

Consideration will be given to

comments and suggestions submitted

within 60 days of this publication.

Dated: October 30, 2000.

Bob Sargis,

Reports Clearance Officer.

[FR Doc. 00–28317 Filed 11–3–00; 8:45 am]

BILLING CODE 4184–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Neurological Devices Panel of the

Medical Devices Advisory Committee;

Notice of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Neurological

Devices Panel of the Medical Devices

Advisory Committee.

General Function of the Committee:

To provide advice and

recommendations to the agency on

FDA’s regulatory issues.

Date and Time: The meeting will be

held on November 16, 2000, 9:30 a.m.

to 7 p.m.

Location: Quality Suites Hotel,

Potomac Rooms II and III, Three

Research Ct., Rockville, MD.

Contact Person: Janet L. Scudiero,

Center for Devices and Radiological

Health (HFZ–410), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–594–1184,

ext. 176, or FDA Advisory Committee

Information Line, 1–800–741–8138

(301–443–0572 in the Washington, DC

area), code 12513. Please call the

Information Line or access the Internet

(http://www.fda.gov/cdrh/

panelmtg.html for up-to-date

information on this meeting.

Agenda: The committee will discuss

and make recommendations on: (1) The

design of clinical trials for devices to

prevent stroke, to treat stroke, and to

provide neurological protection after

stroke; and (2) the design of clinical

studies for temperature control devices

to provide neurological protection.

Procedure: On November 16, 2000,

from 10 a.m. to 7 p.m., the meeting is

open to the public. Interested persons

may present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by November 9, 2000. On

November 16, 2000, oral presentations

from the public will be scheduled

between approximately 11 a.m. and

11:30 a.m. for the discussion of the

design of clinical studies for devices to

prevent stroke, to treat stroke, and to

provide neurological protection after

stroke, and between approximately 4:30

p.m. and 5 p.m. for the discussion of the

design of clinical studies for

temperature control devices to provide

neurological protection. Time allotted

for each presentation may be limited.

Those desiring to make formal oral

presentations should notify the contact

person before November 9, 2000, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Closed Committee Deliberations: On

November 16, 2000, from 9:30 a.m. to 10

a.m., the meeting will be closed to

permit FDA to present to the committee

trade secret and/or confidential

commercial information (5 U.S.C.

552b(c)(4)) regarding pending issues and

applications.

FDA regrets that it was unable to

publish this notice 15 days prior to the

November 16, 2000, Neurological

Devices Panel of the Medical Devices

Advisory Committee meeting. Because

the agency believes there is some

urgency to bring these issues to public

discussion and qualified members of the

Neurological Devices Panel of the

Medical Devices Advisory Committee

were available at this time, the

Commissioner of Food and Drugs

concluded that it was in the public

interest to hold this meeting even if

there was not sufficient time for the

customary 15-day public notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: October 31, 2000.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 00–28445 Filed 11–1–00; 4:34 pm]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Center for Research

Resources; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.

66548 Federal Register / Vol. 65, No. 215 / Monday, November 6, 2000 / Notices

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Center for

Research Resources Special Emphasis Panel

Comparative Medicine.

Date: November 20, 2000.

Time: 2:00 pm to 3:00 pm.

Agenda: To review and evaluate grant

applications.

Place: Office of Review, National Center for

Research Resources, 6705 Rockledge Drive,

Bethesda, MD 20892 (Telephone Conference

Call).

Contact Person: John D. Harding, PhD,

Scientific Review Administrator, Office of

Review, National Center for Research

Resources, 6705 Rockledge Drive, MSC 7965,

Room 6018, Bethesda, MD 20892–7965, (301)

435–0810.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333;

93.371, Biomedical Technology; 93.389,

Research Infrastructure, National Institutes of

Health, HHS)

Dated: October 30, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–28337 Filed 11–3–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Child Health and Human Development

Special Emphasis Panel Teleconference

Review of R25 application.

Date: December 6, 2000.

Time: 12:00 pm to 1:00 pm.

Agenda: To review and evaluate grant

applications.

Place: 6100 Executive Blvd., Room 5E01,

Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Jon M. Ranhand, PhD,

Scientist Review Administrator, Division of

Scientific Review, National Institute of Child

Health, and Human Development, NIH, 6100

Executive Blvd., Room 5E03, Bethesda, MD

20892, (301)435–6884.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.209, Contraception and

Infertility Loan Repayment Program; 93.864,

Population Research; 93.865, Research for

Mothers and Children; 93.929, Center for

Medical Rehabilitation Research, National

Institutes of Health, HHS)

Dated: October 30, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–28335 Filed 11–3–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of General Medical

Sciences; Notice of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

General Medical Sciences Special Emphasis

Panel.

Date: November 3, 2000.

Time: 2:00 pm to 3:00 pm.

Agenda: To review and evaluate grant

applications.

Place: National Institutes of Health,

NIGMS, Office of Scientific Review, Natcher

Building, Room 1AS19, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Arthur L. Zachary, PhD,

Office of Scientific Review, National Institute

of General Medical Sciences, National

Institutes of Health, Natcher Building, Room

1AS–13H, Bethesda, MD 20892, (301) 594–

2886, zacharya@nigms.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.375, Minority Biomedical

Research Support; 93.821, Cell Biology and

Biophysics Research; 93.859, Pharmacology,

Physiology, and Biological Chemistry

Research; 93.862, Genetics and

Developmental Biology Research; 93.88,

Minority Access to Research Careers; 93.96,

Special Minority Initiatives, National

Institutes of Health, HHS)

Dated: October 30, 2000.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–28336 Filed 11–3–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Child Health and Human Development

Special Emphasis Panel Teleconference

Review of 1 R13 application.

Date: December 6, 2000.

Time: 11:00 a.m to 12:00 pm.

Agenda: To review and evaluate grant

application.

Place: 6100 Executive Blvd., Room 5E01,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Jon M. Ranhand, PhD,

Scientist Review Administrator, Division of

Scientific Review, National Institute of Child

Health, and Human Development, NIH, 6100

Executive Blvd., Room 5E0#, Bethesda, MD

20892, (301) 435–6884.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.209, Contraception and

Infertility Loan Repayment Program; 93.864,